PAMS
Pictet Asset Management (Switzerland)’s Biogen BIIB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | $356M | Buy |
1,249,054
+140,688
| +13% | +$40.1M | 0.42% | 60 |
|
2023
Q1 | $308M | Buy |
1,108,366
+398,460
| +56% | +$111M | 0.39% | 64 |
|
2022
Q4 | $197M | Buy |
709,906
+15,681
| +2% | +$4.34M | 0.28% | 105 |
|
2022
Q3 | $185M | Buy |
694,225
+183,164
| +36% | +$48.9M | 0.28% | 110 |
|
2022
Q2 | $104M | Sell |
511,061
-27,759
| -5% | -$5.66M | 0.14% | 191 |
|
2022
Q1 | $113M | Buy |
538,820
+35,494
| +7% | +$7.48M | 0.13% | 201 |
|
2021
Q4 | $121M | Sell |
503,326
-173,436
| -26% | -$41.6M | 0.12% | 204 |
|
2021
Q3 | $192M | Buy |
+676,762
| New | +$192M | 0.21% | 138 |
|